Promoting local medicine production in LMICs like Pakistan is vital for ensuring access to essential medications. Active Pharmaceutical Ingredients (APIs) play a crucial role, not just in quality but also in cost. Pakistan’s API promotion Policy is a proactive step, driving growth and ensuring health security. By learning from regional successes and fostering local industries, ...
Bridging the Gap: Improving Palliative Care Access in Rural Nepal
Palliative care is a lifeline for those with life-threatening illnesses, yet Nepal faces hurdles in accessing essential medications and services, especially in rural areas. Limited studies highlight the demand, but quality healthcare remains out of reach. It’s time for policy changes, including medication inclusion, professional training, and comprehensive research. Together, let’s ensure every patient receives ...
WHO’s Fair Pricing Forum 2024: Enhancing Access to Essential Medicines
The WHO’s virtual Fair Pricing Forum from February 6th to 8th, 2024, focused on equitable access to essential medicines. Stakeholders, including Member States and private sectors, discussed enhancing market transparency and strategies for affordable healthcare. Despite invitation-only participation, the forum emphasized collaboration in addressing global health access challenges. To read more
Global Call for Transparency: Reject Secrecy Clauses in Drug Procurement
Demand Transparency in Drug Procurement! Civil society urges major health programs to reject secrecy clauses hindering global access to essential medicines. Let’s ensure fair pricing and equitable access for all! #TransparencyNow #GlobalHealth Over 50 groups worldwide are calling for transparency in medicine procurement. Join us in advocating for fair terms and pricing to ensure everyone ...
Portuguese Global Medicines Access Index 2021: Hospital Medicines Accessibility
Exciting new research alert! The Portuguese Global Medicines Access Index 2021 offers a groundbreaking indicator to assess access to hospital medicines. Led by Sofia Oliveira-Martins and her team, this study identified key dimensions affecting access, including innovative medicines, distribution, shortages, and value-based healthcare. Their findings, published in the Journal of Value in Health Regional Issues, ...
Africa’s COVID-19 Vaccine Supply: Urgency for Local Production
Sudip Chaudhuri from the Indian Institute of Management, Calcutta published a paper on December 16, 2023, discussing challenges in #covid19 vaccine supply for import-dependent developing countries, particularly in Africa. Emphasizing the need for local production, the paper reviews ongoing efforts and calls for proactive measures, including government intervention, to build manufacturing capacities. Read more
Assessing Antibiotic Availability in Pakistan: Public vs Private Healthcare Disparities
A study led by Sunaina Rafi explores the availability of essential antibiotics in public and private healthcare sectors in Pakistan. Conducted between August 15 and September 10, 2020, the research categorizes 103 antibiotics into Access, Watch, Reserve, and anti-tuberculosis groups. Findings reveal significant challenges, with public facilities showing a mean on-spot availability of 23.76%, contrasting ...
5th International PPRI Conference: Vienna 2024!
Join the 5th International PPRI Conference in Vienna on April 25-26, 2024! Engage with top-tier academics, policymakers, and stakeholders to explore innovative pharmaceutical policies for affordable access to medicines. Submit abstracts by January 15, 2024, for a chance to present in dedicated sessions. Details at https://ppri.goeg.at/ppriconference2024. Don’t miss the chance to shape future policies!
Around 70,000 children are at risk worldwide due to defective cancer medicine
Reporting by the Bureau of Investigative Journalism, in partnership with STAT, reveals that at least a dozen brands of the crucial childhood cancer drug, asparaginase, have been proven to be poor quality. In some cases, brands fell well below the standard needed to treat cancer, and many have also been found to contain contaminants such ...
Enabel: Making quality health products accessible to all
One of our members, Enabel is organizing together with the Africa CDC and other partners from Africa a high-level conference on “Making quality health products accessible to all – Towards an Africa-EU partnership in global health”. Three main areas will be covered: Structural solutions for equitable access to quality health products; access to and transfer ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.